Markets
PTH

Analysts Anticipate PTH To Hit $54

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the PowerShares DWA Healthcare Momentum Portfolio ETF (Symbol: PTH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $53.70 per unit.

With PTH trading at a recent price near $47.40 per unit, that means that analysts see 13.30% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of PTH's underlying holdings with notable upside to their analyst target prices are Surgical Care Affiliates Inc (Symbol: SCAI), Cynosure Inc (Symbol: CYNO), and VWR Corp (Symbol: VWR). Although SCAI has traded at a recent price of $41.45/share, the average analyst target is 35.10% higher at $56.00/share. Similarly, CYNO has 19.30% upside from the recent share price of $51.25 if the average analyst target price of $61.14/share is reached, and analysts on average are expecting VWR to reach a target price of $32.83/share, which is 18.23% above the recent price of $27.77. Below is a twelve month price history chart comparing the stock performance of SCAI, CYNO, and VWR:

SCAI, CYNO, and VWR Relative Performance Chart

Combined, SCAI, CYNO, and VWR represent 5.27% of the PowerShares DWA Healthcare Momentum Portfolio ETF. Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
PowerShares DWA Healthcare Momentum Portfolio ETF PTH $47.40 $53.70 13.30%
Surgical Care Affiliates Inc SCAI $41.45 $56.00 35.10%
Cynosure Inc CYNO $51.25 $61.14 19.30%
VWR Corp VWR $27.77 $32.83 18.23%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

10 ETFs With Most Upside To Analyst Targets »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PTH

Other Topics

ETFs